RT Journal Article
SR Electronic
T1 Detecting post-stroke aphasia using EEG-based neural envelope tracking of natural speech
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.14.23287194
DO 10.1101/2023.03.14.23287194
A1 De Clercq, Pieter
A1 Kries, Jill
A1 Mehraram, Ramtin
A1 Vanthornhout, Jonas
A1 Francart, Tom
A1 Vandermosten, Maaike
YR 2023
UL http://medrxiv.org/content/early/2023/03/17/2023.03.14.23287194.abstract
AB After a stroke, approximately one-third of patients suffer from aphasia, a language disorder that impairs communication ability. The standard behavioral tests used to diagnose aphasia are time-consuming, require subjective interpretation, and have low ecological validity. As a consequence, comorbid cognitive problems present in individuals with aphasia (IWA) can bias test results, generating a discrepancy between test outcomes and everyday-life language abilities. Neural tracking of the speech envelope is a promising tool for investigating brain responses to natural speech. The envelope of speech is crucial for speech understanding, encompassing cues for detecting and segmenting linguistic units, e.g., phrases, words and phonemes. In this study, we aimed to test the potential of the neural envelope tracking technique for detecting language impairments in IWA.We recorded EEG from 27 IWA in the chronic phase after stroke and 22 healthy controls while they listened to a 25-minute story. We quantified neural envelope tracking in a broadband frequency range as well as in the delta, theta, alpha, beta, and gamma frequency bands using mutual information analysis. Besides group differences in neural tracking measures, we also tested its suitability for detecting aphasia at the individual level using a Support Vector Machine (SVM) classifier. We further investigated the required recording length for the SVM to detect aphasia and to obtain reliable outcomes.IWA displayed decreased neural envelope tracking compared to healthy controls in the broad, delta, theta, and gamma band, which is in line with the assumed role of these bands in auditory and linguistic pro-cessing of speech. Neural tracking in these frequency bands effectively captured aphasia at the individual level, with an SVM accuracy of 84% and an area under the curve of 88%. Moreover, we demonstrated that high-accuracy detection of aphasia can be achieved in a time-efficient (5 minutes) and highly reliable manner (split-half reliability correlations between R=0.62 and R=0.96 across frequency bands).Our study shows that neural envelope tracking of natural speech is an effective biomarker for language impairments in post-stroke aphasia. We demonstrated its potential as a diagnostic tool with high reliability, individual-level detection of aphasia, and time-efficient assessment. This work represents a significant step towards more automatic, objective, and ecologically valid assessments of language impairments in aphasia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Research Foundation Flanders and the ERCAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of UZ KU Leuven gave ethical approval for this work (study number S60007)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesWe shared our neural tracking outcomes (i.e. the TMIFs) on the Open Science Framework: https://osf.io/nkmfa/. Note that our ethical approval does not permit public archiving of raw neuroimaging data but raw EEG data can be made available upon request and if the GDPR-related conditions are met.